On Feb. 24, the FDA approved revisions to the safety labeling for nevirapine tablets and oral suspension (Viramune, made by Boehringer Ingelheim Pharmaceuticals, Inc) to warn of the risk of ...
Roche announced that the U.S. Food and Drug Administration (FDA) has approved combination therapy with Pegasys (peginterferon alfa-2a), a pegylated interferon, and Copegus (ribavirin) for the ...
March 3, 2005 — The U.S. Food and Drug Administration (FDA) has approved candesartan cilexitil for use in chronic heart failure with left ventricular dysfunction to reduce the risk of mortality and ...
ZURICH (MarketWatch) -- Swiss pharmaceutical company Roche Holding AG (RHHBY) and Chugai Pharmaceutical Co. (4519.TO) said Friday a combination of Copegus and Pegasys has been approved in Japan for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results